Trial Profile
A Retrospective Study Investigating the Effect of Conversion to Sirolimus in Renal Transplant Patients with or without Prior Malignancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2017
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Cancer; Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 17 Nov 2017 New trial record